Andrew A. F. Hack's Net Worth

$425 Million

Estimate Recalculated Feb 20, 2024 06:38PM EST

Who is Andrew A. F. Hack?

Andrew A. F. Hack has an estimated net worth of $425 Million. This is based on reported shares across multiple companies, which include DYNAVAX TECHNOLOGIES CORP, Atea Pharmaceuticals, Inc., Editas Medicine, Inc., Nuvalent, Inc., BCLS Acquisition Corp., Mersana Therapeutics, Inc., and Allena Pharmaceuticals, Inc..

SEC CIK

Andrew A. F. Hack's CIK is 0001657434

Past Insider Trading and Trends

2018 was Andrew A. F. Hack's most active year for acquiring shares with 20 total transactions. Andrew A. F. Hack's most active month to acquire stocks was the month of April. 2018 was Andrew A. F. Hack's most active year for disposing of shares, totalling 31 transactions. Andrew A. F. Hack's most active month to dispose stocks was the month of January. 2020 saw Andrew A. F. Hack paying a total of $36,524,462.58 for 10,670,777 shares, this is the most they've acquired in one year. In 2022 Andrew A. F. Hack cashed out on 4,500,000 shares for a total of $61,440,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DYNAVAX TECHNOLOGIES CORP (DVAX) Snapshot price: $12.905

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-62.11%
-1.50M
$14.39
-$21,585,000.00
915K
Aug 8
Form 4
-17.15%
-500.00K
$12.68
-$6,340,000.00
2.42M
Jun 14
Form 4
+100.00%
5.36K
10.71K
May 26
Form 4
-25.54%
-1.00M
$10.55
-$10,550,000.00
2.92M
May 18
Form 4
-27.70%
-1.50M
$11.60
-$17,400,000.00
3.92M
Dec 6
Form 4
-35.65%
-3.00M
$14.68
-$44,040,000.00
5.42M
Aug 15
Form 4
0
0
May 26
Form 4
-1.28%
-109.00K
$16.22
-$32,440,000.00
8.41M
Aug 27
Form 4
-0.01%
-1.00K
$10.80
-$24,300,000.00
8.52M
Aug 9
Form 4
0
0
Jun 10
Form 4
0
0
May 28
Form 4
0
0
May 28
Form 4
+13.29%
1M
$5.00
$5,000,000.00
8.53M
May 27
Form 4
0
0
Mar 11
Form 3
0
0
Form 4
0
0
Aug 12
No matching records found

Atea Pharmaceuticals, Inc. (AVIR) Snapshot price: $4.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
5.62M
$24.00
5.62M
Nov 3
Form 4
0
0
Oct 29
Form 3
0
0
No matching records found

Editas Medicine, Inc. (EDIT) Snapshot price: $7.15

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
$13.94
-$102,804.45
0
Scheduled
Feb 4
Form 4
0
$14.48
-$112,000.00
0
Scheduled
Jan 4
Form 4/A
5.28K
$3.23
$17,067.32
5.28K
Scheduled
Nov 23
Form 4/A
6K
$3.23
$19,380.00
6K
Scheduled
Oct 26
Form 4
0
$17.31
-$114,498.44
0
Scheduled
Nov 23
Form 4
0
$16.09
-$115,320.00
0
Scheduled
Oct 26
Form 4
0
$19.28
-$204,800.00
0
Scheduled
Sep 28
Form 4
0
$19.35
-$257,500.00
0
Scheduled
Aug 31
Form 4
0
$25.28
-$267,110.00
0
Scheduled
Jun 1 - Jun 4
Form 4
0
$27.26
-$864,600.00
0
Scheduled
Mar 16 - Mar 20
Form 4
0
$20.35
-$499,200.00
0
Scheduled
Feb 14 - Feb 16
Form 4
0
0
Feb 7
Form 4
0
$13.96
-$314,149.18
0
Scheduled
Dec 15 - Dec 19
Form 4
0
$14.16
-$218,505.00
0
Scheduled
Nov 17 - Nov 20
Form 4
0
0
Mar 1
Form 4
0
$11.22
-$47,910.00
0
Scheduled
Feb 15
Form 4
0
$11.22
-$239,550.00
0
Scheduled
Jan 11
Form 3
0
0
No matching records found

Nuvalent, Inc. (NUVL) Snapshot price: $78.58

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 15
Form 4
+4.35%
149.25K
$33.50
$4,999,975.50
3.58M
Nov 3
Form 4
0
0
Jun 16
Form 4
3.43M
$17.00
3.43M
Aug 2
Form 4
0
0
Jul 28
Form 3
0
0
No matching records found

BCLS Acquisition Corp. No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
487.5K
$10.00
$4,875,000.00
487.5K
Oct 26
Form 3
0
0
No matching records found